OBJECTIVES: Surgeons needing human cardiovascular tissue for implantation in their patients are confronted with cardiovascular tissue banks that use different methods to identify and decontaminate micro-organisms. To elucidate these differences, we compared the quality of processing methods in 20 tissue banks and 1 reference laboratory. We did this to validate the results for accepting or rejecting tissue. We included the decontamination methods used and the influence of antibiotic cocktails and residues with results and controls. The minor details of the processes were not included.
INTRODUCTION
Since the founding of the heart valve bank at the National Heart Hospital in London [1] , the practice by which cardiovascular tissue banks receive cardiac human donor organs and tissues from deceased or living donors has persisted for more than 50 years [2, 3] . The demand from cardiac surgeons for safe tissue grafts of consistent quality for implantation in their patients has been the impetus for continuity among cardiovascular tissue banks.
Whereas graft quality in general is guaranteed by directives and legislation [4] , the processing methods of tissue banks often differ considerably. Such is the case with cardiovascular tissue bank processes [5] .
In short, the practical tissue banking process is as follows: The donor of the received cardiac tissues is screened for transmittable diseases and contraindications for using these tissues for implantation into human recipients [6] . When no contraindications are present, the tissues are treated and tested for microbiological sterility, processed and stored (with a final sterility control) until needed for transplantation.
Subsequently, implantation of tissue grafts takes place in the operating theatres of the recipients' hospitals. In each step of the process, there is a risk that microbiological contamination may occur [7] .
The idea for a quality round, whereby cardiovascular tissue banks compare the results of microbiological tests during their tissue processing procedures, finds its origins in the fact that microbiological decontamination protocols in European tissue banks differ significantly, partly due to differences in endemic microflora and in patented processes. Even when these methods have been validated, the results may differ [8] .
Organizing quality rounds, in which standardized samples are sent to different laboratories for testing and resulting comparisons, is an accepted method to measure the quality of the outcomes [9, 10] .
This study provides an inventory of the methods of 20 participating cardiovascular tissue banks worldwide, most of which are in Europe. In this way, the entire process related to microbiological decontamination is checked. Additionally, the purpose of the study was to demonstrate the possibility of executing quality rounds comparing the differences in methods used by tissue banks.
METHODS

Validation of the quality round method
Sending the same contaminated heart valves to tissue banks, following their standard procedures of testing, decontamination and control and comparing these results with those from other tissue banks and the reference laboratory is a proven method to validate all procedures of all participating banks.
Validation of the quality round method took place in 2 stages of testing.
The first validation test took place in January 2014. The Centraalbureau voor Schimmelcultures of the Royal Netherlands Academy of Sciences validated the method for the quality and transport of freeze-dried bacteriological samples.
These freeze-dried samples were sent to 7 different European cardiovascular tissue banks and to 1 reference microbiology laboratory, all of which scored above average [11] .
The second validation was done in January 2015. Tissue samples of donated valves contaminated with commensal flora were sent to 4 laboratories, using the same transport method for hearts after cardiectomy, i.e. in saline on melting ice. The results were 100% equal in all 4 laboratories.
The results and organizational findings from the validation tests were used to improve and finalize the protocol for the third quality round, as described in the 'Quality round with donated human tissue' section below.
Quality round with donated human tissue
In September 2015, the third quality round was executed. The strains were isolated from the donated cardiac tissue, cultured and checked twice by a reference laboratory.
After contamination, the samples were packed in a sterile container with saline. Samples were then packed and dispatched to the participating tissue banks according to the European Directives (94/55/EC) for Transportation of Biomaterials.
Logistics
Transportation temperatures were validated at 3 different levels by the reference laboratory: 32 C, refrigerated at 6 C and at room temperature +20 C. In September 2015, the samples were sent to the 20 participating tissue banks. They were sent midweek to avoid weekend delays. The time between contamination and delivery at the address of the tissue banks was within 24 h. The start of the investigations, i.e. the culturing of the samples, occurred 6 h to 168 h after delivery. There were no differences in the culture results between those that were started early and those that were started late.
Instructions for the laboratories on how to process the samples were given on an insert. After the specimens were received, they were processed and tested in accordance with the procedures of the individual tissue banks. All results were sent back to the reference centre and were received by December 2015. Tissue banks described the essentials of their processing: which antibiotic cocktail they used, how long they incubated the tissue, at which temperature and if they rinsed or neutralized the antibiotics and checked to see whether any residuals were left.
Reference laboratory
For Sample A, the reference laboratory correctly identified both micro-organisms-Enterococcus faecalis and Escherichia coli. For 50% of Sample B, coagulase-negative Staphylococcus was identified, whereas in the other 50% of the samples, Streptococcus anginosus, coagulase-negative Staphylococcus and Escherichia coli were correctly identified. The reference laboratory isolated S.
anginosus from only 1 of the 2 samples tested. Therefore, S. anginosus was excluded from the score.
RESULTS
The results of all of the 20 participating cardiovascular tissue banks were collated (Table 1) :
Seventeen tissue banks scored tissue Sample A correctly. Three tissue banks either missed the Enterococcus (2) or the E. coli (1).
Seventeen tissue banks scored tissue Sample B correctly. Two tissue banks missed the coagulase-negative Staphylococcus and 1 bank received a sample contaminated with Enterococcus, probably due to cross-contamination with Sample A. All tissue banks used a cocktail of 3 to 6 different antibiotics to decontaminate the tissue. The antibiotic cocktails that were in use are as follows: 17 tissue banks used vancomycin, 11 used gentamicin and 10 tissue banks used antifungal drugs (mainly amphotericin or nystatin).
Specific anaerobic coverage (such as metronidazole, cefoxitin, sulbactam and tazobactam) was used by 11 tissue banks; 9 tissue banks did not cover anaerobic micro-organisms. Similarly, 10 banks did not cover fungi (Table 1 , column 4) and 2 banks did not cover enterococci (which was one of the contaminants in the trial).
The goal of the decontamination protocol that the tissue banks use is to disinfect the tissue by immersion and incubation in a mixture of the aforementioned antibiotics. Most (60%) contain vancomycin and aminoglycoside (Table 1 , column 4). The tissues were incubated for a minimum of 6 h in 1 bank, and a maximum of 48 h in 4 banks. All other banks used time periods between 6 and 48 h ( Table 1 , column 5).
Sixteen tissue banks immersed the tissue during decontamination at a temperature of 2 C to 8 C, and 4 tissue banks decontaminated the samples at room temperature or 37 C (see Table 2 ). Of these last 4 tissue banks, 2 had a negative culture after decontamination.
As can be seen in Table 2 , only 7 tissue banks had a negative microbiological culture after decontamination with antibiotics.
Five tissue banks found only 1 of the 2 samples to be negative (4 times in Sample B).
Seven tissue banks found the last-sterility-check culture to be negative, but only 3 tissue banks would release the tissue for implantation; the other 4 rejected the tissue. All other tissue banks (13) would reject the tissues. So, most tissue banks discarded the tissue, whatever the results of their controls.
Only 6 tissue banks rinsed the tissue or neutralized the tissue to get rid of antibiotic residues after decontamination. They did not indicate whether they tested the tissue for antibiotic residues and/or whether their methods were validated.
DISCUSSION
Decontamination of cardiovascular allografts is a step in the tissue banking process aimed at eliminating micro-organisms from the donor or contamination from cardiectomy team members. Thus, this step in the process contributes to the safety of the allograft required by the implanting surgeon.
In this study, decontamination was shown not to be effective in 13 tissue banks because of growth after decontamination. The literature revealed that antibiotics are effective at 36 C [6, 12, 13] and not, or less so, at 2 C to 8 C. If microbes were found and identified, almost all tissue banks would reject the tissues, even when micro-organisms were not isolated from the tissue after decontamination. If a sample was already positive for micro-organisms at the first control, which is mostly the transport fluid, it would be rejected anyway [14] . However, tissue banks do complete the entire process because cultures usually become available several days after processing, which means considerable work with associated additional costs.
The reason why tissue banks, using a validated method, reject tissue that is negative for micro-organisms in the final control, is probably the risk of sampling error. Samples taken during processing consist of a biopsy from the valve and fluid samples from the irrigating and immersion solutions used to decontaminate and rinse the valves. The more fluid and tissue they check, the more reliable are the results. A second reason to reject the sample could be the methods of culturing, which should be up to date according to the microbiological quality handbooks for clinical specimens. Comparing the sampling and culturing methods could be a subject for the next quality round. No tissue banks reported a change of method as a consequence of the results of the first quality round. Those tissue banks that would still deviate after a second quality round need to seriously consider a change in their procedures in this regard.
One-hundred percent sterilization would only be achieved by applying rigorous methods, such as radiation or heat sterilization. However, such methods would damage the valve tissue and make cardiovascular grafts unfit for implantation. The decontamination procedure, if it is validated, would ensure that the tissue contained no known micro-organisms. If there were no other contraindications, the tissue could be used for implantation. There are no recent reports of recipients of donated tissues developing infections due to the transplants they received, although 1 study showed that 9.5% of cultures taken from thawed valves just before implantation were positive for bacteria [15] , but no adverse reactions were found in the recipients. An infection in recipients who receive bone tissue or corneal transplants is also rare.
It is advisable to validate procedures and methods by always taking cultures from homografts at the time of implantation or during a specific period of time. Most tissue banks use extremely high concentrations of antibiotics for decontamination, much higher than those used in clinical situations. After decontamination, the tissues should ideally be rinsed, or even better, the residual antibiotics on the tissues should be neutralized. If not, the presence of antibiotics can induce bacteriostasis of micro-organisms, which will lead to false-negative results in all the tested samples [16, 17] . Perhaps even worse, there is a risk that the antibiotics can cause severe allergic or toxic reactions in tissue recipients [18, 19] . There were no current studies that reported on this issue and how serious the clinical consequences may be. There is a risk that recipients who have an allergy to specific antibiotics could develop allergic reactions after transplantation as a result of extremely high concentrations of antibiotics in the tissues [20, 17] . Because recipients are treated with antibiotics prophylactically, it would be difficult to prove, and there are no known recent clinical reports of a reaction caused by an antibiotic residue on the tissue allograft. Rinsing of grafts is standard practice in most tissue banks as well as clinically before implantation.
Also, residues of dimethyl sulphoxide, a cryoprotective fluid used for valve preservation, can cause renal and hepatic dysfunction and cardiovascular complications locally [21] . Soquet et al. describe the acute rejection of a cryopreserved arterial homograft of unknown origin that could be caused by the residual contents of antibiotics, dimethyl sulphoxide or damaged tissue proteins [22] .
Many antibiotics (such as beta-lactam) do not work better in higher concentrations. On the contrary, the higher the dosage, the more toxic their effects may be on the recipient; the effect on graft survival is unknown.
Antibiotic cocktails disturb the intrinsic properties of tissues, enzymatic activities and immunological events. The presence of antibiotic lipids has been described in skin, cornea and amniotic membranes [17] . Furthermore, most antibiotics need multiplying micro-organisms to eliminate them, and cell replication does not happen at 4 C. If the tissue is immersed at a temperature of 4 C, the antibiotics will only be absorbed by the tissue, giving a falsenegative result in the post-antibiotic incubation tissue culture. However, after weeks of incubation, the tissue might contain a slow-growing microbial population that could cause a chronic problem at the implantation site of the tissue recipient [12] . It is recommended that one use a temperature that allows bacteria to grow well (36 C) and then use the antibiotic cocktail at a low clinical dose for only 6 h, because immersion for more than 6 h does not provide better results [8, 16] .
The use of antibiotics means that there is an obligation to rinse the tissue after the decontamination procedure. The European and the US Pharmacopoeias recommend eliminating from samples any factor that may interfere with microbial growth during sterility testing [18] . As was shown previously, there are a number of ways to achieve this goal [23, 24] .
Limitations
Cardiovascular tissue banks use concentrations of antibiotics that differ considerably in composition and concentration. An earlier survey showed that concentrations of, e.g. vancomycin vary from 50 mg/ml to 1000 mg/ml and of gentamicin from 50 mg/ml to 4000 mg/ml, which is up to 400 times more than what is clinically used in patients [5] . The composition and concentration of antibiotics contribute to the level of toxic effect on the tissue cells. So, one question that remains unanswered in this study is the influence of these different concentrations of antibiotics on structural and biomechanical properties of the tissue matrix and of the valve leaflets. Although this unanswered question is a limitation of this study, the study of biomechanics requires a different group of specialists.
CONCLUSIONS
A surgeon who wishes to implant a cardiovascular tissue graft from a reliable source is confronted with cardiovascular tissue banks that have their own, often locally validated, methods of tissue sampling and processing and their own regimens for decontamination of antibiotics [8] . In addition, at this time, no consistent, quality parameter for microbiological decontamination exists. By using quality rounds to validate the practices of the various cardiovascular tissue banks, we can identify those cardiovascular tissue banks whose tissue processing methods (nontoxic) deviate from appropriate standards. Quality rounds will identify where the processing methods used are insufficient and need to be changed in conjunction with an agreed minimal protocol, accepted by the entire tissue bank community, for validation of sampling and testing, taking into consideration all of the different parameters used in those tissue banks.
In the first trial with the freeze-dried tissues, the microbiological culture results of the tissue banks were assessed and the scores were above average. However, there was some room for improvement [12] . In this study, the entire processing chains of 20 participating tissue banks were evaluated, including the antibiotic decontamination regimens, tissue rinsing methods, postantibiotic incubation (if any) and the sampling technique.
This method of sending contaminated tissues to be processed by the tissue bank according to local standard procedures and testing them pre-and post-decontamination, and assessing the microbiological culture results, is an effective way of validating the processes of the participating tissue banks. It also demonstrates that the majority of tissue banks, 17 of 20, can save costs and manpower if they rely totally on the outcomes of their own procedures.
By repeating this method over time, it may be expected that the differences in processing, the interpretation of the results and, finally, the decision to release tissues for transplantation may be harmonized by the individual tissue banks [25] .
Before harmonization has been achieved, surgeons must be aware of the techniques applied in the cardiovascular tissue bank that provides the allografts they use, especially when a graft comes from a supplier whose methods are unknown. Sampling at implantation is advised.
To prevent discarding scarce allografts, tissue banks should alter their procedures such that they rely on their own method of decontamination and not reject grafts if a non-specified micro-organisms, which could be neutralized, is found. Specifically, this argument gains additional weight when the decontamination method has been validated. Differences between methods used by tissue banks may lead to incorrect outcomes of microbiological testing. Only when harmonization and validation of methods are achieved will surgeons and colleagues from cardiovascular tissue banks be able to rely fully on one another's methods and have confidence in the consistent sterility of the tissue grafts and uniform quality criteria in the event that tissues for implanting are exchanged across borders.
